2013
DOI: 10.1146/annurev-biophys-083012-130338
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Basis of NF-κB Signaling

Abstract: NF-κB (nuclear factor kappa B) family transcription factors are master regulators of immune and inflammatory processes in response to both injury and infection. In the latent state, NF-κBs are sequestered in the cytosol by their inhibitor IκB (inhibitor of NF-κB) proteins. Upon stimulations of innate immune receptors such as Toll-like receptors and cytokine receptors such as those in the TNF (tumor necrosis factor) receptor superfamily, a series of membrane proximal events lead to the activation of the IKK (Iκ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

12
621
0
5

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 778 publications
(639 citation statements)
references
References 133 publications
12
621
0
5
Order By: Relevance
“…These are the mediators released by reactive astrocytes modulating immune cell invasion after injury (Burda and Sofroniew, 2014). Specifically NF‐κB signaling has been implicated in gene expression events that impact on cell survival, differentiation, and proliferation (Napetschnig and Wu, 2013; Oeckinghaus et al, 2011). Interestingly, cyclin D1 (Ccnd1), a known NF‐κB target (Guttridge et al, 1999; Hinz et al, 1999), is also significantly upregulated in reactive astrocytes (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…These are the mediators released by reactive astrocytes modulating immune cell invasion after injury (Burda and Sofroniew, 2014). Specifically NF‐κB signaling has been implicated in gene expression events that impact on cell survival, differentiation, and proliferation (Napetschnig and Wu, 2013; Oeckinghaus et al, 2011). Interestingly, cyclin D1 (Ccnd1), a known NF‐κB target (Guttridge et al, 1999; Hinz et al, 1999), is also significantly upregulated in reactive astrocytes (Fig.…”
Section: Discussionmentioning
confidence: 99%
“…The activated (phosphorylated) IκK subunits, IκKβ and IκKα, in turn phosphorylate IκBα, marking pSer 32,36 -IκBα for proteasomal degradation. 1,10 In addition, activated IκKβ phosphorylates p65, promoting translocation of the transcription factor to the nucleus where it drives gene expression, including the induction of Bcl-xL. 11,12 Consistent with this model, pharmacologic inhibition of NF-κB signaling in primary thymocytes and cancer cell lines blocks Bcl-xL induction and increases cell death in response to treatment with apoptosis-inducing antibodies or exposure to DNA damage.…”
mentioning
confidence: 86%
“…1 NF-κB is critically involved in the inhibition of apoptosis by transcribing genes encoding caspase inhibitors as well as multi-domain anti-apoptotic Bcl-2 family members such as Bcl-xL. 2 Bcl-xL antagonizes multiple steps of the apoptotic program at the endoplasmic reticulum (ER)-mitochondria interface.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Reporter cells were incubated with each treatment at 37 °C in 5% CO 2 for 8 h. The transcriptional level of the luciferase gene that is downstream of the NF-κB responsive element is a sensitive surrogate indicator of NF-κB activation state (Lemon and Tjian. 2000;Napetschnig and Wu. 2013), therefore NF-κB activation was quantified by luciferase mRNA level via q-PCR.…”
Section: In Vitro Evaluation Of Nf-κb Activation and The Effect Of VImentioning
confidence: 99%